We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Pegasystems
PEGA
$5.02B
| $1.91M | ﹤0.01% |
87,206
+3,956
| +5% | +$80.2K |
|
1577
United Fire Group
UFCS
$1.32B
| $1.91M | ﹤0.01% |
44,605
+12,211
| +38% | +$549K |
|
|
ARRY
1578
DELISTED
Array Biopharma Inc
ARRY
| $1.91M | ﹤0.01% |
213,082
+11,500
| +6% | +$122K |
|
1579
iShares Russell 2000 Growth ETF
IWO
$14.3B
| $1.9M | ﹤0.01% |
11,775
+6,435
| +121% | +$1.02M |
|
1580
BJ's Restaurants
BJRI
$1.42B
| $1.9M | ﹤0.01% |
47,026
+8,053
| +21% | +$298K |
|
|
KRA
1581
DELISTED
Kraton Corporation
KRA
| $1.9M | ﹤0.01% |
61,293
+15,846
| +35% | +$442K |
|
1582
MiMedx Group
MDXG
$602M
| $1.89M | ﹤0.01% |
198,372
+56,110
| +39% | +$474K |
|
1583
Coeur Mining
CDE
$15.4B
| $1.89M | ﹤0.01% |
233,783
+26,225
| +13% | +$250K |
|
1584
Delek US
DK
$4.16B
| $1.89M | ﹤0.01% |
77,790
+2,615
| +3% | +$62.1K |
|
1585
Universal Electronics
UEIC
$57.8M
| $1.89M | ﹤0.01% |
27,554
+8,099
| +42% | +$535K |
|
|
ARI
1586
Apollo Commercial Real Estate
ARI
$867M
| $1.88M | ﹤0.01% |
99,986
+11,050
| +12% | +$196K |
|
1587
Diodes
DIOD
$3.78B
| $1.87M | ﹤0.01% |
77,826
+20,658
| +36% | +$514K |
|
|
PINC
1588
DELISTED
Premier
PINC
| $1.87M | ﹤0.01% |
58,811
+11,731
| +25% | +$368K |
|
1589
RingCentral
RNG
$4.66B
| $1.87M | ﹤0.01% |
66,130
+3,082
| +5% | +$76.2K |
|
|
PKY
1590
DELISTED
Parkway, Inc.
PKY
| $1.86M | ﹤0.01% |
93,673
+26,581
| +40% | +$555K |
|
|
PRSU
1591
Pursuit Attractions and Hospitality Inc
PRSU
$1.39B
| $1.86M | ﹤0.01% |
41,131
+11,283
| +38% | +$510K |
|
1592
Green Plains
GPRE
$1.18B
| $1.85M | ﹤0.01% |
74,945
+19,507
| +35% | +$464K |
|
|
SCS
1593
DELISTED
Steelcase
SCS
| $1.85M | ﹤0.01% |
110,490
+3,819
| +4% | +$63.1K |
|
|
DEL
1594
DELISTED
Deltic Timber
DEL
| $1.85M | ﹤0.01% |
23,700
+6,001
| +34% | +$460K |
|
1595
National Healthcare
NHC
$3.53B
| $1.85M | ﹤0.01% |
25,926
+11,680
| +82% | +$864K |
|
1596
Central Pacific Financial
CPF
$1.02B
| $1.85M | ﹤0.01% |
60,493
+17,627
| +41% | +$547K |
|
1597
Lindsay Corp
LNN
$1.13B
| $1.84M | ﹤0.01% |
20,936
+5,158
| +33% | +$404K |
|
1598
Marten Transport
MRTN
$1.21B
| $1.84M | ﹤0.01% |
196,733
+31,205
| +19% | +$295K |
|
|
AYR
1599
DELISTED
Aircastle Ltd
AYR
| $1.84M | ﹤0.01% |
76,434
-1,692
| -2% | -$39.2K |
|
1600
G-III Apparel Group
GIII
$1.54B
| $1.84M | ﹤0.01% |
84,090
+22,911
| +37% | +$584K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.